Iguana Healthcare Management, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+40,860
(23.3%)
New positions
20
Sold out positions
22
Turnover %
43.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Medtronic PLC | 6,770 | NEW |
| BIIB | 5,071 | 60.5% |
| Horizon Therapeutics PLC Com | 4,838 | NEW |
| THE CIGNA GROUP | 3,790 | 86.6% |
| PFE | 3,212 | NEW |
| ALXN | 3,043 | NEW |
| MRK | 2,879 | 32.9% |
| RARE | 2,689 | NEW |
| TEVA | 2,642 | NEW |
| Impax Laboratories, LLC | 2,574 | 204.8% |
Top Reduces (Value $000, Stocks/ETFs)
| COVIDIEN PLC | -3,405 | -100.0% |
| ARTHROCARE CORP | -3,018 | -100.0% |
| GILD | -2,841 | -44.5% |
| INTERMUNE INC | -2,210 | -100.0% |
| DXCM | -2,125 | -100.0% |
| EXPRESS SCRIPTS HLDG CO | -1,756 | -100.0% |
| EW | -1,644 | -100.0% |
| MDXG | -1,573 | -100.0% |
| VRTX | -1,486 | -100.0% |
| A | -1,430 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
56,710
(26.2% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|